SentiAR, a St. Louis-based company that has developed visualization technologies for surgical applications, has raised $8.5 million in Series B funding that will allow it to accelerate commercialization of its mixed reality CommandEP system.
Their system, the first FDA cleared application of its kind, integrates existing imaging systems to create a real-time 3D holographic interface that provides physicians with a more precise way to deliver cardiac ablation therapy to treat arrhythmia patients.
The latest investment was led by Cultivate (MD) Ventures and joined by MedVenture Partners and other insider investors. The funding is expected to allow the company to launch new partnerships and deploy the technology more widely. The company expects completion of new clinical studies later this year.
SentiAR technology is based on the developments at Washington University in St. Louis by Jennifer Silva, MD, a pediatric cardiologist and associate professor of pediatrics at Washington University School of Medicine, and Jonathan Silva, the Dennis & Barbara Kessler Career Development Associate Professor in the Department of Biomedical Engineering in the McKelvey School of Engineering.
Washington University licensed the technology from the Silva lab to SentiAR, which is further developing the augmented reality software. SentiAR has funding from the National Institutes of Health as well as St. Louis investment firms Cultivation Capital and BioGenerator.